Stephens Inc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.32M | Sell |
2,951
-143
| -5% | -$66.7K | 0.02% | 570 |
|
|
2025
Q4 | $1.4M | Sell |
3,094
-470
| -13% | -$203K | 0.02% | 555 |
|
|
2025
Q3 | $1.4M | Buy |
3,564
+172
| +5% | +$71.9K | 0.02% | 561 |
|
|
2025
Q2 | $1.51M | Buy |
3,392
+77
| +2% | +$35.5K | 0.02% | 522 |
|
|
2025
Q1 | $1.61M | Sell |
3,315
-138
| -4% | -$64.3K | 0.02% | 517 |
|
|
2024
Q4 | $1.39M | Sell |
3,453
-95
| -3% | -$44K | 0.02% | 524 |
|
|
2024
Q3 | $1.65M | Sell |
3,548
-160
| -4% | -$76.9K | 0.02% | 485 |
|
|
2024
Q2 | $1.74M | Sell |
3,708
-360
| -9% | -$156K | 0.03% | 459 |
|
|
2024
Q1 | $1.7M | Buy |
4,068
+43
| +1% | +$18.2K | 0.03% | 458 |
|
|
2023
Q4 | $1.64M | Sell |
4,025
-320
| -7% | -$118K | 0.03% | 440 |
|
|
2023
Q3 | $1.51M | Sell |
4,345
-59
| -1% | -$20.6K | 0.03% | 440 |
|
|
2023
Q2 | $1.55M | Sell |
4,404
-300
| -6% | -$101K | 0.03% | 441 |
|
|
2023
Q1 | $1.48M | Buy |
4,704
+274
| +6% | +$82.2K | 0.03% | 456 |
|
|
2022
Q4 | $1.28M | Sell |
4,430
-274
| -6% | -$83.5K | 0.03% | 463 |
|
|
2022
Q3 | $1.36M | Sell |
4,704
-1,755
| -27% | -$505K | 0.03% | 453 |
|
|
2022
Q2 | $1.82M | Sell |
6,459
-1,000
| -13% | -$268K | 0.04% | 403 |
|
|
2022
Q1 | $1.95M | Sell |
7,459
-4,044
| -35% | -$960K | 0.03% | 427 |
|
|
2021
Q4 | $2.53M | Sell |
11,503
-2,496
| -18% | -$485K | 0.04% | 404 |
|
|
2021
Q3 | $2.54M | Sell |
13,999
-3,588
| -20% | -$701K | 0.04% | 407 |
|
|
2021
Q2 | $3.55M | Sell |
17,587
-74
| -0.4% | -$15.5K | 0.05% | 360 |
|
|
2021
Q1 | $3.79M | Buy |
17,661
+2,058
| +13% | +$452K | 0.06% | 306 |
|
|
2020
Q4 | $3.69M | Buy |
15,603
+2,730
| +21% | +$626K | 0.07% | 292 |
|
|
2020
Q3 | $3.5M | Buy |
12,873
+1,939
| +18% | +$535K | 0.07% | 274 |
|
|
2020
Q2 | $3.17M | Buy |
10,934
+2,465
| +29% | +$668K | 0.07% | 281 |
|
|
2020
Q1 | $2.02M | Sell |
8,469
-211
| -2% | -$48.4K | 0.05% | 344 |
|
|
2019
Q4 | $1.9M | Sell |
8,680
-1,980
| -19% | -$401K | 0.04% | 411 |
|
|
2019
Q3 | $1.81M | Sell |
10,660
-309
| -3% | -$54.7K | 0.04% | 409 |
|
|
2019
Q2 | $2.01M | Sell |
10,969
-371
| -3% | -$64.9K | 0.05% | 401 |
|
|
2019
Q1 | $2.09M | Sell |
11,340
-533
| -4% | -$98.4K | 0.05% | 390 |
|
|
2018
Q4 | $1.97M | Buy |
11,873
+200
| +2% | +$34.7K | 0.06% | 358 |
|
|
2018
Q3 | $2.25M | Buy |
+11,673
| New | +$2.08M | 0.06% | 374 |
|
|
2017
Q3 | – | Sell |
-13,315
| Closed | -$1.72M | – | 877 |
|
|
2017
Q2 | $1.72M | Buy |
13,315
+143
| +1% | +$17.2K | 0.06% | 322 |
|
|
2017
Q1 | $1.44M | Buy |
+13,172
| New | +$1.16M | 0.05% | 348 |
|
|
2013
Q3 | – | Sell |
-2,920
| Closed | -$234K | – | 846 |
|
|
2013
Q2 | $234K | Buy |
+2,920
| New | +$215K | 0.01% | 601 |
|
Other funds holding VRTX
VCM
VPM
Stephens Inc's VRTX Position: Q1 2026 in Review
Stephens Inc reduced its Vertex Pharmaceuticals (VRTX) stake by 4.6% in Q1 2026, selling an estimated $66.7K and leaving 2,951 shares worth $1.32M. The position accounts for 0.02% of the portfolio, ranked #570.
Stephens Inc first reported a position in VRTX in Q2 2013 and has held it in 34 quarters since. The position peaked at $3.79M in Q1 2021. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Stephens Inc held 2,951 shares of Vertex Pharmaceuticals worth $1.32M as of Q1 2026.
- Stephens Inc sold 143 Vertex Pharmaceuticals shares in Q1 2026, an estimated $66.7K.
- Vertex Pharmaceuticals made up 0.02% of Stephens Inc's portfolio in Q1 2026, its #570 holding.
- Stephens Inc first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 34 quarters since.
- Stephens Inc's Vertex Pharmaceuticals position peaked at $3.79M in Q1 2021.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Stephens Inc's 13F filing for Q1 2026, filed 28 Apr 2026.